Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities
Sign Up to like & getrecommendations! Published in 2020 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-020-05709-1
Abstract: Immune checkpoint inhibitors (ICIs) have emerged as the newest pillar of cancer treatment, transforming outcomes in melanoma and showing benefit in a range of malignancies. Immune-mediated toxicities, stemming from increased activity within the T cell… read more here.
Keywords: management immune; management; mediated toxicities; practice ... See more keywords
Real-World Incidence and Management of Immune-Related Adverse Events from Immune Checkpoint Inhibitors: Retrospective Claims-Based Analysis
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Investigation"
DOI: 10.1080/07357907.2021.1913502
Abstract: Abstract Purpose We assessed real-world spectrum and patterns of irAEs for patients treated with anti-PD(L)1 ICIs. Methods irAEs were defined using medical and pharmacy claims for patients enrolled in a Medicare Advantage Prescription Drug plan… read more here.
Keywords: real world; management immune; world incidence; incidence management ... See more keywords
Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies
Sign Up to like & getrecommendations! Published in 2019 at "Neurology"
DOI: 10.1212/wnl.0000000000008091
Abstract: Objective To describe the spectrum, clinical course, and management of neuropathies associated with immune checkpoint inhibitors (ICIs). Methods Patients with ICI-related neuropathy (irNeuropathy) were identified and their clinical characteristics compared to neuropathy attributed to cytotoxic… read more here.
Keywords: management; management immune; phenotypes management; immune checkpoint ... See more keywords
The Diagnosis and Management of Immune Checkpoint Inhibitor Cardiovascular Toxicity: Myocarditis and Beyond
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10020304
Abstract: Recent years have brought major advancements in the use of immune therapy and specifically immune checkpoint inhibitors (ICIs) in cancer patients, with expanding indications for various malignancies resulting in the treatment of a large and… read more here.
Keywords: immune checkpoint; management immune; toxicity; diagnosis management ... See more keywords